Expand PLX Menu
PLX MENU

PLX Stock Summary and Trading Ideas (Protalix Biotherapeutics (De) | AMEX:PLX)

Charts for Today's Stock Price and Implied Volatility in Protalix Biotherapeutics (De)

11-Oct-2024

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for PLX by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Protalix Biotherapeutics (De) (PLX) Frequently Asked Questions

What does Protalix Biotherapeutics (De) do?

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.

What symbol and exchange does Protalix Biotherapeutics (De) shares trade?

Protalix Biotherapeutics (De) trades on the AMEX stock market under the symbol PLX.

What is Protalix Biotherapeutics (De) stock price doing today?

As of October 11, 2024, PLX stock price climbed to $1.08 with 287,426 million shares trading.

What is Protalix Biotherapeutics (De)'s Beta?

PLX has a beta of 0.90, meaning it tends to be less sensitive to market movements. PLX has a correlation of 0.04 to the broad based SPY ETF.

How much is Protalix Biotherapeutics (De) worth?

PLX has a market cap of $79.43 million. This is considered a Micro Cap stock.

How much money does Protalix Biotherapeutics (De) make?

Last quarter Protalix Biotherapeutics (De) reported $13 million in Revenue and -$.03 earnings per share. This beat revenue expectation by $974,000 and missed earnings estimates by -$.05.

What is the highest and lowest price Protalix Biotherapeutics (De) traded in the last 3 year period?

In the last 3 years, PLX traded as high as $3.55 and as low as $.70.

What are the top ETFs holding Protalix Biotherapeutics (De)?

The top ETF exchange traded funds that PLX belongs to (by Net Assets): IWC.

Is Protalix Biotherapeutics (De) (PLX) a good investment?

PLX has underperformed the market in the last year with a return of -30.3%, while the SPY ETF gained +34.4%. In the last 3 month period, PLX fell short of the market, returning -5.3%, while SPY returned +4.5%. However, in the most recent 2 weeks PLX has outperformed the stock market by returning +2.9%, while SPY returned +1.4%.

What are the support and resistance levels for Protalix Biotherapeutics (De) (PLX)?

PLX support price is $.97 and resistance is $1.03 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PLX shares will trade within this expected range on the day.